Skip to main content

Table 3 Differences in Epstein Barr virus (EBV) antibody levels among controls, by risk factors for classical Kaposi sarcoma

From: Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

  mean difference*
(95% CI)
Cofactor EBNA-1 VCA
Age, continuous 0.00 (-0.02 to 0.02) 0.02 (0.00 to 0.04)
Sex   
Male
Female
-1.21 (-1.78 to -0.64)
Reference
-2.14 (-2.67 to -1.62)
Reference
Smoking status   
Never
Former
Current
-0.62 (-1.30 to 0.07)
-0.82 (-1.41 to -0.23)
Reference
-2.37 (-3.01 to -1.73)
-1.09 (-1.64 to -0.54)
Reference
Diabetes   
Yes
No
-0.82 (-1.29 to -0.34)
Reference
-0.84 (-1.29 to -0.40)
Reference
Cortisone use in last 10 years   
Yes
No
-0.41 (-0.89 to 0.06)
Reference
-0.46 (-0.89 to -0.02)
Reference
KSHV antibody status   
Positive
Negative
0.18 (-0.22 to 0.59)
Reference
0.11 (-0.27 to 0.49)
Reference
  1. * Mean difference from multivariate linear regression models that included all variables shown.